News › Clinical Practice, Industry News, Patient Care

Restylane Brand Shares First-of-its-kind Phase IV Kissability Study Results

July 14, 2020

The Restylane brand has announced results of a first-of-its-kind phase IV, Kissability study for an injectable hyaluronic acid (HA) lip filler, evaluating not only subject satisfaction, but also, for the first time, partner satisfaction following treatment with Restylane Kysse. Many consumers report they often keep their lip treatments a secret and have concerns about partner perceptions after injection. In the Kissability study, all subjects (100%) and a majority of their partners (90%) were satisfied with their lips after Restylane Kysse treatment, with most partners (73%) reporting a more kissable and natural feel.
Read more at PR Newswire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • The Beauty Health Company (SKIN) Rebrands to SkinHealth Systems
    • Amazon Launches GLP-1 Weight Loss Program with One Medical
    • Botox Cosmetic’s “The Confidence Collective” to Empower 250 Women Entrepreneurs
    • Medical Spa Show 2027 Call for Presentations Now Open
    • FDA Warning Letter to Texas Medical Spa Signals Increased Compliance Enforcement